This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Illumina Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hsu-lin Tsao: Innovator in Nucleic Acid Sequencing Technology
Introduction
Hsu-lin Tsao is a prominent inventor based in San Diego, California. He has made significant contributions to the field of nucleic acid sequencing, particularly through his innovative patent that enhances the analysis of nucleic acid sequences. His work is vital for advancements in genetic research and diagnostics.
Latest Patents
Hsu-lin Tsao holds a patent titled "Incremental secondary analysis of nucleic acid sequences." This patent encompasses methods, systems, and apparatuses, including computer programs, for performing incremental secondary analysis of nucleic acid sequence reads. The method involves obtaining first data from a nucleic acid sequencing device during a first read interval and second data during a subsequent read interval. The process includes mapping and alignment of the reads to a reference sequence, which is crucial for accurate genetic analysis.
Career Highlights
Hsu-lin Tsao is associated with Illumina Corporation, a leading company in the field of genomics. His work at Illumina has positioned him as a key player in the development of advanced sequencing technologies. His innovative approach has contributed to the company's reputation for excellence in genetic research tools.
Collaborations
Hsu-lin Tsao has collaborated with notable colleagues, including Michael J. Carney and Jacobus De Beer. These collaborations have fostered a productive environment for innovation and have led to significant advancements in the field of nucleic acid sequencing.
Conclusion
Hsu-lin Tsao's contributions to nucleic acid sequencing technology through his patent and work at Illumina Corporation highlight his role as an influential inventor in the field. His innovative methods are paving the way for future advancements in genetic research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
